Biosimilar Peptide Mapping Characterization and MAM Workflow Using Prototype Benchtop QTOF with an App-Based Acquisition and Data Processing Platform

Posters | 2022 | WatersInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Industries
Pharma & Biopharma
Manufacturer
Waters
Downloadable PDF for viewing
 

Similar PDF

Biosimilar Peptide Mapping Characterization and MAM Workflow Using Prototype Benchtop QTOF with an App-Based Acquisition and Data Processing Platform
Applying Peptide Mapping and Multi- Attribute Method (MAM) Workflow for Biosimilar mAb Drug Products Comparison on the Xevo™ G3 QTof Platform
PEPTIDE CHARACTERIZATION AND MONITORING WORKFLOW FOR BIOSIMILAR mAb DRUG PRODUCTS USING A COMPLIANCE READY LC-MS AND INFORMATICS PLATFORM
Comprehensive Biosimilar Comparability Assessment via Intact and Subunit RP-MS and IEX-UV-MS Using the Xevo™ G3 QTof System